Free Trial
→ Want to target extra income every week? (From Jack Carter Trading) (Ad) Free NAMS Stock Alerts

NewAmsterdam Pharma (NAMS) Institutional Ownership

NewAmsterdam Pharma logo
$23.55 +0.13 (+0.56%)
As of 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMS)

Current
Institutional Ownership
Percentage
89.89%
Number of
Institutional Buyers
(last 12 months)
39
Total
Institutional Inflows
(last 12 months)
$260.76M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$2.56M
Get NAMS Insider Trade Alerts

Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NAMS Institutional Buying and Selling by Quarter

NewAmsterdam Pharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/15/2025 HB Wealth Management LLC8,728$224K0.0%N/A0.009%
12/26/2024JPMorgan Chase & Co.22,351$371K0.0%+176.9%0.024%
11/19/2024Barclays PLC7,596$126K0.0%+1,813.4%0.008%
11/16/2024Geode Capital Management LLC86,322$1.43M0.0%+1.6%0.096%
11/15/2024M&T Bank Corp27,328$454K0.0%+54.1%0.030%
11/15/2024Frazier Life Sciences Management L.P.12,855,194$213.40M8.6%+5.1%14.282%
11/15/2024Barclays PLC7,596$126K0.0%+1,813.4%0.008%
11/15/2024XTX Topco Ltd11,265$187K0.0%N/A0.013%
11/15/2024Wellington Management Group LLP92,223$1.53M0.0%+11.0%0.102%
11/15/2024State Street Corp37,915$629K0.0%+168.7%0.042%
11/15/2024Quarry LP6,500$108K0.0%+2,469.2%0.007%
11/15/2024Readystate Asset Management LP121,000$2.01M0.0%N/A0.134%
11/15/2024Parkman Healthcare Partners LLC105,334$1.75M0.2%-22.2%0.117%
11/15/2024Janus Henderson Group PLC1,540,729$25.61M0.0%+51.1%1.712%
11/15/2024Cinctive Capital Management LP66,571$1.11M0.1%+77.7%0.074%
11/15/2024ArrowMark Colorado Holdings LLC354,975$5.89M0.1%+19.5%0.394%
11/14/2024Bellevue Group AG7,700$128K0.0%N/A0.009%
11/14/2024Walleye Capital LLC46,947$779K0.0%N/A0.052%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC239,283$3.97M0.0%+1,231.0%0.266%
11/13/2024FMR LLC330,412$5.49M0.0%+35.6%0.367%
11/12/2024HealthInvest Partners AB138,983$2.31M1.1%+83.4%0.154%
11/8/2024Jennison Associates LLC1,020,278$16.94M0.0%+8.9%1.133%
11/5/2024GSA Capital Partners LLP66,402$1.10M0.1%+79.9%0.074%
11/4/2024Lisanti Capital Growth LLC42,165$700K0.2%N/A0.047%
11/4/2024Wolverine Asset Management LLC4,944$82K0.0%-68.2%0.005%
11/4/2024TimesSquare Capital Management LLC255,245$4.24M0.1%+3.7%0.284%
10/25/2024abrdn plc129,060$2.14M0.0%+69.8%0.143%
10/23/2024Moody Aldrich Partners LLC216,493$3.59M0.7%-1.9%0.241%
10/21/2024Venture Visionary Partners LLC10,000$166K0.0%-9.1%0.011%
8/15/2024Millennium Management LLC1,165,429$22.39M0.0%+23.0%1.295%
8/15/2024Deerfield Management Company L.P. Series C869,250$16.70M0.3%+30.3%0.966%
8/15/2024Decheng Capital LLC400,000$7.68M2.4%N/A0.445%
8/15/2024Affinity Asset Advisors LLC423,155$8.13M0.9%+47.9%0.470%
8/14/2024Marshall Wace LLP21,831$419K0.0%-81.1%0.024%
8/13/2024Sei Investments Co.24,561$472K0.0%+49.1%0.027%
8/2/2024Wolverine Asset Management LLC15,524$298K0.0%+117.7%0.017%
7/31/2024Banque Cantonale Vaudoise2,000$38K0.0%N/A0.002%
7/12/2024Rosalind Advisors Inc.10,123$194K0.1%N/A0.011%
5/29/2024Opaleye Management Inc.315,388$7.46M1.6%+18.8%0.351%
5/17/2024Artal Group S.A.800,000$18.92M0.5%N/A0.896%
5/16/2024Janus Henderson Group PLC636,231$15.02M0.0%N/A0.713%
5/15/2024Baker BROS. Advisors LP96,827$2.29M0.0%N/A0.108%
5/15/2024Affinity Asset Advisors LLC286,200$6.77M0.8%+129.0%0.321%
5/14/2024StemPoint Capital LP80,334$1.90M0.5%N/A0.090%
5/7/2024TimesSquare Capital Management LLC228,616$5.41M0.1%N/A0.256%
5/2/2024Jennison Associates LLC930,851$22.02M0.0%N/A1.043%
4/10/2024 Yarbrough Capital LLC23,960$567K0.0%N/A0.027%
3/7/2024Fcpm Iii Services B.V.11,831,461$132.16M39.2%N/A14.373%
2/15/2024Opaleye Management Inc.265,388$2.96M0.8%N/A0.325%
2/15/2024Parkman Healthcare Partners LLC300,750$3.36M0.5%+20.8%0.369%
2/1/2024Wolverine Asset Management LLC8,694$97K0.0%+197.2%0.011%
11/15/2023Affinity Asset Advisors LLC125,000$1.16M0.3%+25.0%0.153%
11/14/2023Schonfeld Strategic Advisors LLC64,700$598K0.0%+12.9%0.079%
11/13/2023Wolverine Asset Management LLC2,925$27K0.0%N/A0.004%
8/21/2023Affinity Asset Advisors LLC100,000$1.19M0.4%N/A0.123%
8/15/2023RA Capital Management L.P.9,000,000$107.01M2.0%+125.0%11.035%
8/15/2023Bain Capital Life Sciences Investors LLC10,473,913$124.54M12.8%+26.2%12.842%
8/10/2023Monashee Investment Management LLC95,000$1.13M0.3%N/A0.116%
8/4/2023Maven Securities LTD25,000$297K0.0%N/A0.031%
7/19/2023Medicxi Ventures Management Jersey Ltd2,869,565$34.12M9.6%+43.5%3.518%
7/14/2023Venture Visionary Partners LLC10,000$119K0.0%N/A0.012%
5/9/2023GMT Capital Corp1,083,800$14.37M0.6%+8.4%6.106%
5/8/2023Wolverine Asset Management LLC4,819$64K0.0%N/A0.027%
2/14/2023RA Capital Management L.P.4,000,000$43.60M0.9%N/A22.535%
2/3/2023Frazier Life Sciences Management L.P.9,341,551$101.82M6.3%N/A52.628%
2/3/2023GMT Capital Corp1,000,000$10.90M0.5%N/A5.634%
1/31/2023Medicxi Ventures Management Jersey Ltd2,000,000$21.80M9.2%N/A11.268%
(Data available from 1/1/2016 forward)

NAMS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NAMS shares?

During the previous two years, 49 institutional investors and hedge funds held shares of NewAmsterdam Pharma. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($213.40M), Fcpm Iii Services B.V. ($132.16M), Bain Capital Life Sciences Investors LLC ($124.54M), RA Capital Management L.P. ($107.01M), Medicxi Ventures Management Jersey Ltd ($34.12M), Janus Henderson Group PLC ($25.61M), and Millennium Management LLC ($22.39M).Learn more on NAMS's institutional investors.

What percentage of NewAmsterdam Pharma stock is owned by institutional investors?

89.89% of NewAmsterdam Pharma stock is owned by institutional investors. Learn more on NAMS's institutional investor holdings.

Which institutional investors have been buying NewAmsterdam Pharma stock?

Of the 47 institutional investors that purchased NewAmsterdam Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fcpm Iii Services B.V. ($11.83M), Frazier Life Sciences Management L.P. ($9.97M), RA Capital Management L.P. ($9M), Medicxi Ventures Management Jersey Ltd ($2.87M), Bain Capital Life Sciences Investors LLC ($2.17M), Janus Henderson Group PLC ($1.16M), and GMT Capital Corp ($1.08M).

How much institutional buying is happening at NewAmsterdam Pharma?

Institutional investors have bought a total of 42,985,717 shares in the last 24 months. This purchase volume represents approximately $538.75M in transactions.

Which NewAmsterdam Pharma major shareholders have been selling company stock?

The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Marshall Wace LLP ($93.55K), Parkman Healthcare Partners LLC ($30.04K), Wolverine Asset Management LLC ($10.58K), Moody Aldrich Partners LLC ($4.17K), and Venture Visionary Partners LLC ($1K).

How much institutional selling is happening at NewAmsterdam Pharma?

Institutional investors have sold a total of 139,345 shares in the last 24 months. This volume of shares sold represents approximately $2.56M in transactions.


Related Companies

This page (NASDAQ:NAMS) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Stunning Trump Exec Order Leaked
This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored
liberals FOOLED by Elon’s shocking surprise
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...
StocksToTrade | Sponsored
Elon’s New AI Firm REVEALED
Nvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...
Paradigm Press | Sponsored
Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...
Weiss Ratings | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored